SCHEMBL743713

SCHEMBL743713

COc1cccc(/C=C/C(=O)c2c(OC)cc(OC)c(C3=CCNC(C)C3)c2O)c1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
CYP1A1 P04798 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
ALOX5 P09917 1/20 0.46
NFE2L2 Q16236 2/20 0.45
MAOB P27338 2/20 0.45
ABCB1 P08183 1/20 0.44
KMT2A Q03164 2/20 0.43
RELA Q04206 4/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
NTSR1 P30989 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MAPT P10636 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MEN1 O00255 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL746548 0.84 NPC1 (0.49) NPC1RAB9ACYP1A1CYP1A2CYP2D6
SCHEMBL746358 0.78 NPC1 (0.46) NPC1RAB9ACYP1A1CYP1A2CYP2D6
SCHEMBL20858962 0.78 RAB9A (0.48) NPC1RAB9ACYP1A1CYP1A2CYP2D6
SCHEMBL746171 0.76 ABCB1 (0.54) NPC1RAB9ACYP1A1CYP1A2CYP2D6
SCHEMBL745621 0.72 ABCG2 (0.53) MAOBABCB1KMT2AMAPTNPSR1
SCHEMBL19183189 0.71 NFE2L2 (0.74) NPC1RAB9ACYP1A1CYP1A2CYP2D6
SCHEMBL19183192 0.71 NFE2L2 (0.74) NPC1RAB9ACYP1A1CYP1A2CYP2D6
SCHEMBL20858960 0.71 RAB9A (0.45) NPC1RAB9ACYP1A1CYP1A2CYP2D6
Hydrochloric Acid SCHEMBL748259 0.71 ABCG2 (0.52) MAOBABCB1KMT2AMAPTNPSR1
SCHEMBL7027348 0.70 NPC1 (0.44) NPC1RAB9ACYP1A1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2429292-A1 COMPOUNDS AND COMPOSITIONS COMPRISING CDK INHIBITORS AND METHODS FOR THE TREATMENT OF CANCER Georgia State University Research Foundation, Inc. (US) 2012-03-21 EP claimed
WO-2010129858-A1 COMPOUNDS AND COMPOSITIONS COMPRISING CDK INHIBITORS AND METHODS FOR THE TREATMENT OF CANCER GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-11-11 WO claimed